What should a MA-C be concerned about when a resident is taking coumadin?

When a resident is taking Coumadin, which is a type of anticoagulant medication, the primary concern for a Medication Assistant - Certified (MA-C) is the increased risk of bleeding. Coumadin functions by inhibiting the action of vitamin K, which is critical for blood clotting. As a result, patients on this medication have a higher likelihood of experiencing bleeding complications, which can occur even from minor injuries or spontaneously without any evident cause.

Monitoring for signs of excessive bleeding, such as unexplained bruising, blood in urine or stool, prolonged bleeding from cuts, or unusual headaches, is vital for anyone on Coumadin. In addition, regular testing of the INR (International Normalized Ratio) is often required to ensure that the blood's clotting ability remains within a therapeutic range, thereby balancing the prevention of blood clots without increasing the risk of dangerous bleeding episodes.

While other concerns such as infections, weight changes, or allergic reactions are important in general nursing care, they are not as directly linked to the medication's primary mechanism and the specific risks associated with its use as the risk of bleeding is. Thus, it is essential for the MA-C to prioritize the monitoring of bleeding risks when managing residents taking Coumadin.